Literature DB >> 21236599

Curcumin regulates low-linear energy transfer γ-radiation-induced NFκB-dependent telomerase activity in human neuroblastoma cells.

Natarajan Aravindan1, Jamunarani Veeraraghavan, Rakhesh Madhusoodhanan, Terence S Herman, Mohan Natarajan.   

Abstract

PURPOSE: We recently reported that curcumin attenuates ionizing radiation (IR)-induced survival signaling and proliferation in human neuroblastoma cells. Also, in the endothelial system, we have demonstrated that NFκB regulates IR-induced telomerase activity (TA). Accordingly, we investigated the effect of curcumin in inhibiting IR-induced NFκB-dependent hTERT transcription, TA, and cell survival in neuroblastoma cells. METHODS AND MATERIALS: SK-N-MC or SH-SY5Y cells exposed to IR and treated with curcumin (10-100 nM) with or without IR were harvested after 1 h through 24 h. NFκB-dependent regulation was investigated either by luciferase reporter assays using pNFκB-, pGL3-354-, pGL3-347-, or pUSE-IκBα-Luc, p50/p65, or RelA siRNA-transfected cells. NFκB activity was analyzed using an electrophoretic mobility shift assay and hTERT expression using the quantitative polymerase chain reaction. TA was determined using the telomerase repeat amplification protocol assay and cell survival using the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltertrazolium bromide and clonogenic assay.
RESULTS: Curcumin profoundly inhibited IR-induced NFκB. Consequently, curcumin significantly inhibited IR-induced TA and hTERT mRNA at all points investigated. Furthermore, IR-induced TA is regulated at the transcriptional level by triggering telomerase reverse transcriptase (TERT) promoter activation. Moreover, NFκB becomes functionally activated after IR and mediates TA upregulation by binding to the κB-binding region in the promoter region of the TERT gene. Consistently, elimination of the NFκB-recognition site on the telomerase promoter or inhibition of NFκB by the IκBα mutant compromises IR-induced telomerase promoter activation. Significantly, curcumin inhibited IR-induced TERT transcription. Consequently, curcumin inhibited hTERT mRNA and TA in NFκB overexpressed cells. Furthermore, curcumin enhanced the IR-induced inhibition of cell survival.
CONCLUSIONS: These results strongly suggest that curcumin inhibits IR-induced TA in an NFκB dependent manner in human neuroblastoma cells.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21236599      PMCID: PMC3071590          DOI: 10.1016/j.ijrobp.2010.10.058

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  37 in total

Review 1.  Molecular targets of dietary agents for prevention and therapy of cancer.

Authors:  Bharat B Aggarwal; Shishir Shishodia
Journal:  Biochem Pharmacol       Date:  2006-02-23       Impact factor: 5.858

2.  Curcumin inhibits formation of amyloid beta oligomers and fibrils, binds plaques, and reduces amyloid in vivo.

Authors:  Fusheng Yang; Giselle P Lim; Aynun N Begum; Oliver J Ubeda; Mychica R Simmons; Surendra S Ambegaokar; Pingping P Chen; Rakez Kayed; Charles G Glabe; Sally A Frautschy; Gregory M Cole
Journal:  J Biol Chem       Date:  2004-12-07       Impact factor: 5.157

3.  Inhibition of radiation induced nitration by curcumin and nicotinamide in mouse macrophages.

Authors:  Himanshi Narang; Malini Krishna
Journal:  Mol Cell Biochem       Date:  2005-08       Impact factor: 3.396

4.  Curcumin inhibits telomerase activity in human cancer cell lines.

Authors:  Shu-Xiang Cui; Xian-Jun Qu; Yan-Ying Xie; Ling Zhou; Munehiro Nakata; Masatoshi Makuuchi; Wei Tang
Journal:  Int J Mol Med       Date:  2006-08       Impact factor: 4.101

5.  Telomerase activity distinguishes between neuroblastomas with good and poor prognosis.

Authors:  C Poremba; H Willenbring; B Hero; H Christiansen; K L Schäfer; C Brinkschmidt; H Jürgens; W Böcker; B Dockhorn-Dworniczak
Journal:  Ann Oncol       Date:  1999-06       Impact factor: 32.976

Review 6.  Telomere and telomerase as targets for anti-cancer and regeneration therapies.

Authors:  Yi-hsin Hsu; Jing-jer Lin
Journal:  Acta Pharmacol Sin       Date:  2005-05       Impact factor: 6.150

7.  hEST2, the putative human telomerase catalytic subunit gene, is up-regulated in tumor cells and during immortalization.

Authors:  M Meyerson; C M Counter; E N Eaton; L W Ellisen; P Steiner; S D Caddle; L Ziaugra; R L Beijersbergen; M J Davidoff; Q Liu; S Bacchetti; D A Haber; R A Weinberg
Journal:  Cell       Date:  1997-08-22       Impact factor: 41.582

8.  Bovine microvascular endothelial cells immortalized with human telomerase.

Authors:  Raphaële Buser; Roberto Montesano; Irène Garcia; Philippe Dupraz; Michael S Pepper
Journal:  J Cell Biochem       Date:  2006-05-15       Impact factor: 4.429

9.  A mammalian telomerase-associated protein.

Authors:  L Harrington; T McPhail; V Mar; W Zhou; R Oulton; M B Bass; I Arruda; M O Robinson
Journal:  Science       Date:  1997-02-14       Impact factor: 47.728

10.  Cloning of human telomerase catalytic subunit (hTERT) gene promoter and identification of proximal core promoter sequences essential for transcriptional activation in immortalized and cancer cells.

Authors:  M Takakura; S Kyo; T Kanaya; H Hirano; J Takeda; M Yutsudo; M Inoue
Journal:  Cancer Res       Date:  1999-02-01       Impact factor: 12.701

View more
  16 in total

1.  In silico evaluation of TERT inhibition by anticancer drugs.

Authors:  Porika Mahendar; Kalam Sirisha; Umasankar Kulandaivelu; Prakhya Laxmi Jaya Shankar; Tippani Radhika; Abbagani Sadanandam
Journal:  J Mol Model       Date:  2012-06-06       Impact factor: 1.810

Review 2.  Phenylpropanoids in radioregulation: double edged sword.

Authors:  Wanyeon Kim; Ki Moon Seong; BuHyun Youn
Journal:  Exp Mol Med       Date:  2011-06-30       Impact factor: 8.718

3.  Acquired tumor cell radiation resistance at the treatment site is mediated through radiation-orchestrated intercellular communication.

Authors:  Natarajan Aravindan; Sheeja Aravindan; Vijayabaskar Pandian; Faizan H Khan; Satish Kumar Ramraj; Praveen Natt; Mohan Natarajan
Journal:  Int J Radiat Oncol Biol Phys       Date:  2014-01-07       Impact factor: 7.038

Review 4.  Emerging therapeutic targets for neuroblastoma.

Authors:  Natarajan Aravindan; Terence Herman; Sheeja Aravindan
Journal:  Expert Opin Ther Targets       Date:  2020-10-06       Impact factor: 6.902

Review 5.  Relationship and interactions of curcumin with radiation therapy.

Authors:  Vivek Verma
Journal:  World J Clin Oncol       Date:  2016-06-10

6.  The prospective role of plant products in radiotherapy of cancer: a current overview.

Authors:  Banasri Hazra; Subhalakshmi Ghosh; Amit Kumar; B N Pandey
Journal:  Front Pharmacol       Date:  2012-01-09       Impact factor: 5.810

7.  Curcumin potentiates rhabdomyosarcoma radiosensitivity by suppressing NF-κB activity.

Authors:  W Shannon Orr; Jason W Denbo; Karim R Saab; Catherine Y Ng; Jianrong Wu; Kui Li; Jo Meagan Garner; Christopher L Morton; Ziyun Du; Lawrence M Pfeffer; Andrew M Davidoff
Journal:  PLoS One       Date:  2013-02-07       Impact factor: 3.240

8.  Molecular basis of 'hypoxic' breast cancer cell radio-sensitization: phytochemicals converge on radiation induced Rel signaling.

Authors:  Sheeja Aravindan; Mohan Natarajan; Terence S Herman; Vibhudutta Awasthi; Natarajan Aravindan
Journal:  Radiat Oncol       Date:  2013-03-04       Impact factor: 3.481

9.  Anti-pancreatic cancer deliverables from sea: first-hand evidence on the efficacy, molecular targets and mode of action for multifarious polyphenols from five different brown-algae.

Authors:  Sheeja Aravindan; Caroline R Delma; Somasundaram S Thirugnanasambandan; Terence S Herman; Natarajan Aravindan
Journal:  PLoS One       Date:  2013-04-16       Impact factor: 3.240

10.  Novel synthetic monoketone transmute radiation-triggered NFκB-dependent TNFα cross-signaling feedback maintained NFκB and favors neuroblastoma regression.

Authors:  Sheeja Aravindan; Mohan Natarajan; Vibhudutta Awasthi; Terence S Herman; Natarajan Aravindan
Journal:  PLoS One       Date:  2013-08-14       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.